Companies: 10,795·Total market cap: $144.5T
Avid Bioservices, Inc.

Avid Bioservices, Inc.

CDMONASDAQHealthcare
$12.49
+$0.00(+0.00%)
Market Cap$798901617
P/E Ratio
52W High$12.51
52W Low$5.9
Overview

Avid Bioservices, Inc. (CDMO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CDMO · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-2.39cdmo eps ttm · cdmo earnings per shareEarnings history
PE Ratio (TTM)cdmo pe ratio ttm · cdmo price to earningsPE Ratio deep dive
Revenue (TTM)$150.4Mcdmo revenue ttm · cdmo annual revenueFull revenue history
Dividend Yield25.34%does cdmo pay dividends · cdmo dividend yieldDividend history
Shares Outstanding63.2Mcdmo shares outstanding · cdmo floatShares outstanding history
Next EarningsTBAcdmo earnings date · cdmo next earningsEarnings history

Financial Snapshot

Full Financials
FY 2024Revenue$139.9M▼ 6.27% YoY
202220232024
avid bioservices, inc. revenue · cdmo revenue 2024
FY 2024Net Income-$140.8M▼ 25234.46% YoY
202220232024
avid bioservices, inc. net income · cdmo profit 2024
FY 2024EPS$-2.23▼ 24877.78% YoY
202220232024
cdmo eps · avid bioservices, inc. earnings per share 2024
TTM:Revenue: $150.4MNet Income: -$152.1MEPS: $-2.39View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy10 analystsis cdmo a buy · cdmo analyst rating
Strong Buy
1
Buy
8
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$8.00Low
$12.49Current
$8.00Avg Target35.95% downside
$8.00High
cdmo price target · cdmo 12 month forecast

Total: 10 · Buy rate: 90.0%

The CDMO analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $8.00, representing -35.95% downside from the current price of $12.49.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+1.71%
YTD+1.38%
1Y+42.09%
5Y+94.85%

About Avid Bioservices, Inc.

CEONicholas Stewart Green MBA
IPO DateApr 4, 1994
Employees371
CountryUS

Avid Bioservices, Inc. operates as a Contract Development and Manufacturing Organization (CDMO), specializing in the development and CGMP-compliant production of biopharmaceutical drug substances. The…

what is avid bioservices, inc. · cdmo stock overview · avid bioservices, inc. company profile · who is avid bioservices, inc. ceo · cdmo NASDAQ · avid bioservices, inc. headquarters · avid bioservices, inc. business segments

About Stock Overview & Key Data

Avid Bioservices, Inc. (CDMO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 4, 1994. As of the latest trading session, CDMO stock price is $12.49, with a market capitalization of $798.9M. The stock has returned +42.09% over the past 12 months and +1.38% year-to-date.

According to 10 Wall Street analysts, the consensus rating for Avid Bioservices, Inc. stock is Buy, with an average 12-month price target of $8.00. In fiscal year 2024, Avid Bioservices, Inc. reported revenue of $139.9M and net income of -$140.8M. For detailed data — including Avid Bioservices, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Avid Bioservices, Inc. (CDMO) stock price is $12.49. The stock is traded on NASDAQ under the ticker symbol CDMO. The 52-week range is $5.90 – $12.51.

CDMO stock priceCDMO quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice